Peer-reviewed articles
(*) corresponding author, (§) denotes a student in the division as author
2012
359. Drolet M, Brisson M(*), Maunsell E, Franco EL, Coutlée F, Ferenczy A, Fisher W, Mansi J. The psychosocial impact of an abnormal cervical smear result: a prospective and comparative study. Psycho-Oncology (in press).
358. Cerigo H, Macdonald ME, Franco EL, Brassard P(*). Inuit Women’s Attitudes and Experiences towards Cervical Cancer and Prevention Strategies in Nunavik, Quebec. International Journal of Circumpolar Health (in press).
357. Ferguson R(§), Ramanakumar AV, Koushik A, Coutlée F, Franco EL, Roger M(*), for the Biomarkers of Cervical Cancer Risk (BCCR) Study Team. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. International Journal of Cancer (in press).
356. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam S, Cain J, Garcia FAR, Moriarty A, Waxman A, Wilbur D, Wentzensen N, Downs L, Spitzer M, Moscicki AB, Saraiya M, Franco EL, Stoler MH, Schiffman M, Castle PE(*), Myers ER(*). American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. This article was jointly published in CA Cancer Journal for Clinicians (in press); American Journal of Clinical Pathology 137-516-542, 2012, and Journal of Lower Genital Tract Disease (in press)
355. Coutlée F(*), de Pokomandy A. Franco EL. Epidemiology, natural history and risk factors for anal intraepithelial neoplasia. Sexual Health (in press).
354. Siegel E, Patel N, Lu B, Lee J-H, Nyitray AG, Craft NE, Frenkel K, Villa LL, Franco EL, Giuliano AR(*). Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: Markers of immune response?. International Journal of Cancer 131: 219-228, 2012.
353. Siegel EM(*), Patel N, Lu B, Lee JH, Nyitray AG, Huang X, Villa LL, Franco EL, Giuliano AR. Circulating Biomarkers of Iron Storage and Clearance of Incidence Human Papillomavirus Infection. Cancer Epidemiology, Biomarkers and Prevention 21: 859-865, 2012.
352. Toporowski A, Harper S, Fuhrer R, Buffler PA, Detels R, Krieger N, Franco EL(*). Burden of Disease, Health Indicators, and Challenges for Epidemiology in North America. International Journal of Epidemiology 41: 540-556, 2012.
351. Mahmud SM(§*), Sangwa-Lugoma G, Nasr SH, Liaras J, Kayembe PK, Tozin RR, Drouin P, Lorincz A, Ferenczy A, Franco EL. Comparison of Human Papillomavirus Testing and Cytology for Cervical Cancer Screening in a Primary Health Care Setting in the Democratic Republic of the Congo. Gynecologic Oncology 124: 286-291, 2012.
350. Lapierre SG, Sauthier P, Mayrand MH, Dufresne S, Petignat P, Provencher D, Drouin P, Gauthier P, Dupuis MJ, Michon B, Ouellet S, Hadjeres R, Ferenczy A, Franco EL, Coutlée F(*). Human Papillomavirus (HPV) DNA Triage of Women with Atypical Squamous Cells of Undetermined Significance (ASC-US) with Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of High-Grade Lesions of the Uterine Cervix. Journal of Clinical Microbiology 50:1240-1244, 2012.
349. Cerigo H, Coutlée F, Franco EL, Brassard P(*). Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec. Journal of Medical Screening 19: 42-48, 2012.
348. Lau S(§), Vaknin Z, Ramana-Kumar AV, Halliday D, Franco EL, Gotlieb WH(*).Outcomes and Cost Comparisons After Introducing a Robotics Program for Endometrial Cancer Surgery. Obstetrics & Gynecology 119: 717-724, 2012.
2011
347. Richardson LA(§), Tota J, Franco EL(*). Optimizing Technology for Cervical Cancer Screening in High-Resource Settings. Expert Review of Obstetrics & Gynecology 6: 343-353, 2011.
346. Legault V, Burchell A, Goggin P, Nicolau B, Forest P, Mayrand MH, Franco EL, Coutlée F(*). Generic Microtiter Plate Assay for Triaging Clinical Specimens prior to Genotyping of HPV DNA via Consensus PCR. Journal of Clinical Microbiology 49: 3977-3979, 2011.
345. Burchell AN(§*), Coutlée F, Tellier PP, Hanley J, Franco EL. Genital transmission of human papillomavirus in recently-formed, heterosexual couples. Journal of Infectious Diseases 204(11):1723-1729, 2011.
344. Tota JE(§), Chevarie-Davis M, Richardson LA, deVries M, Franco EL(*). Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Preventive Medicine 53 (Suppl 1): S12-21, 2011.
343. Drolet M, Brisson M(*), Maunsell E, Franco EL, Coutlée F, Ferenczy A, Ratnam S, Fisher W, Mansi J. The impact of anogenital warts on health-related quality of life: a 6-month prospective study. Sexually Transmitted Diseases 38: 949-956, 2011.
342. Sangwa-Lugoma G(§), Ramanakumar AV, Mahmud S, Liaras J, Kayembe PK, Tozin RR, Lorincz A, Franco EL(*). Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community. Sexually Transmitted Diseases 38(4): 308-315, 2011.
341. Vanni T(§*), Legood R, Franco EL, Villa LL, Luz PM, Schwartsmann G. Economic evaluation of strategies for managing women with equivocal cytological results in Brazil. International Journal of Cancer 129(3): 671-679, 2011.
340. Brisson M(*), Van De Velde N, Franco EL, Drolet M, Boily MC. Incremental impact of adding boys to current hpv vaccination programmes: role of herd immunty. Journal of Infectious Diseases 204(3): 372-376, 2011.
339. Coutlée F(*), Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. Journal of Medical Virology 83:1034-1041, 2011.
338. Sénécal M(*), Brisson M, Maunsell E, Ferenczy A, Franco EL, Ratnam S, Coutlée F, Palefsky JM, Mansi JA. Loss of quality of life associated with genital warts: baseline analyses from a prospective study. Sexually Transmitted Infection 87:209-215, 2011.
337. de Pokomandy A(§), Rouleau D, Ghattas G, Trottier H, Vézina S, Coté P, Macleod J, Allaire G, Hadjeres R, Franco EL, Coutlée F(*). HAART and Progression to High-Grade Anal Intraepithelial Neoplasia in Men Who Have Sex with Men and Are Infected with HIV. Clinical Infectious Diseases 52:1174-1181, 2011.
336. Ferguson R(§), Ramanakumar AV, Richardson H, Tellier PP, Coutlée F, Franco EL, Roger M(*).Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. Human Immunology 72(4):337-341, 2011.
335. Tomita LY(§), Roteli-Martins CM, Villa LL, Franco EL, Cardoso MA(*), for the BRINCA Study Team. Associations of dietary dark green and deep yellow vegetables and fruits with cervical intraepithelial neoplasia: modification by smoking. British Journal of Nutrition 105: 928-937, 2011.
334. Mahmud SM(*§), Franco EL, Turner D, Platt RW, Beck P, Skarsgard D, Tonita J, Sharpe C, Aprikian AG. Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A population-based nested case-control study. Public Library of Science – One 6(1):e16412, 2011.
333. Cerigo H, MacDonald ME, Franco EL, Brassard P(*). Awareness and knowledge about human papillomavirus among Inuit women in Nunavik, Quebec. Journal of Community Health 36: 56-62, 2011.
332. Franco EL. Foreword. Future Medicine, DOI:10.2217/EBO.11.82:2-5, 2011
331. Dufresne S, Sauthier P, Mayrand MH, Petignat P, Provencher D, Drouin P, Gauthier P, Dupuis MJ, Michon B, Ouellet S, Hadjeres R, Ferenczy A, Franco EL, Coutlée F(*). Human Papillomavirus (HPV) DNA triage of women with Atypical Squamous Cells of Undetermined Significance (ASCUS) with AMPLICOR HPV and Hybrid Capture 2 Assays for the Detection of High-grade Lesions of the Uterine Cervix. Journal of Clinical Microbiology 49: 48-53, 2011.